COMMUNIQUÉS West-GlobeNewswire

Acology Canada Markets Heat Up, Big Sales Increases, LPs On Board

16/01/2018 - 14:30

CORONA, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTC MARKETS: ACOL ) reports sharp increases in sales throughout Canada as the country edges towards total legalization later this year. Sales of Acology’s [...]

Dyadic International, Inc. Announces Research and Development Collaboration with the Israel Institute for Biological Research (IIBR) to Combat Emerging Diseases & Threats

16/01/2018 - 14:30

JUPITER, Fla., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]

Arbutus Announces Closing of the Second Tranche of a $116M Strategic Investment from Roivant Sciences

16/01/2018 - 14:30

VANCOUVER, British Columbia and WARMINSTER, Pa., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading hepatitis B virus (HBV) therapeutic solutions company, today [...]

Precipio Appoints New Sales VP to Manage Diagnostics Sales Expansion

16/01/2018 - 14:27

NEW HAVEN, Conn., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ: PRPO ) has appointed Douglas Sites to the new position of Vice President of Sales where he will be responsible for [...]

Krystal Biotech, Inc. Announces Granting of U.S. Composition of Matter Patent Covering Herpes Simplex Virus (HSV) Vectors and Methods of Using the Same to Treat Skin Diseases

16/01/2018 - 14:00

PITTSBURGH, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS ), a gene therapy company advancing “off-the-shelf,” treatments for dermatological diseases, today announced that the United States [...]

HTG Molecular Announces Third Statement of Work for New Clinical Assay Development Program

16/01/2018 - 14:00

TUCSON, Ariz., Jan. 16, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced it has [...]

PetMed Express D/B/A 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 22, 2018

16/01/2018 - 14:00

DELRAY BEACH, Fla., Jan. 16, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS ) will announce its financial results for the quarter ended December 31, 2017 on Monday, January 22, 2018 at 8:00 A.M. Eastern [...]

Interface People (IPeople) and Novaseek Research Announce Partnership

16/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Interface People (IPeople), a premiere healthcare integration provider and Novaseek Research, Inc., a health IT for life sciences organization, today announced a [...]

Athenex Receives Positive Feedback from FDA on the Design of Phase III Clinical Trial for Oraxol

16/01/2018 - 14:00

BUFFALO, N.Y., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Biotricity Announces the Addition of Artificial Intelligence to its Remote Patient Monitoring Platform

16/01/2018 - 14:00

REDWOOD CITY, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

RedHill Biopharma Announces Final Results from Phase II Study with BEKINDA® for IBS-D

16/01/2018 - 14:00

TEL-AVIV, Israel and RALEIGH, N.C., Jan. 16, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Mitochondrial assay breakthrough announced by Biolog

16/01/2018 - 13:45

HAYWARD, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Biolog, Inc. announced today the launch of a new product line that enables a comprehensive scan of mitochondrial function. Better technology for measuring mitochondrial [...]

Transactions in relation to share buyback program

16/01/2018 - 13:39

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Innovation Pharmaceuticals Presents at 2018 Biotech Conference; Oral Mucositis Drug Candidate Garners Exceptional Interest After Successful Phase 2 Trial

16/01/2018 - 13:30

BEVERLY, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders of a productive appearance by [...]

AveXis Announces Proposed Public Offering of Common Stock

16/01/2018 - 13:25

CHICAGO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ) today announced that it intends to offer and sell, subject to market conditions, up to $400 million of shares of its common stock in an [...]

Saniona AB: Saniona initiates Phase I study with new Tesomet tablet

16/01/2018 - 13:20

PRESS RELEASE January 16, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that it has dosed the first 10 participants in a Phase 1 pharmacokinetic study of Tesomet using the new [...]

AveXis Announces Expanded Clinical Development Program for AVXS-101 in Spinal Muscular Atrophy

16/01/2018 - 13:20

– Company to expand study of AVXS-101 into additional SMA populations including pre-symptomatic, older pediatric Type 2 and Type 3 SMA patients – – First patient dosed in Phase 1 trial of AVXS-101 in SMA Type 2 – [...]

FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY

16/01/2018 - 13:01

Company release January 16, 2018 at 2:00 PM EET NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY The shareholders of FIT Biotech Oy are invited to an extraordinary general meeting, which is to be held [...]

Midatech and UCSF receive IND approval for DIPG treatment MTX110

16/01/2018 - 13:01

16 January 2018 Midatech Pharma PLC ("Midatech", "Company" or "Group") Midatech and UCSF receive IND approval for DIPG treatment MTX110 - First treatment in patients in US expected as scheduled in Q1 2018 Midatech [...]